1.13
price up icon40.72%   0.327
after-market Dopo l'orario di chiusura: 1.15 0.02 +1.77%
loading

Aspire Biopharma Holdings Inc Borsa (ASBP) Ultime notizie

pulisher
Mar 25, 2026

Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack - The State Journal-Register

Mar 25, 2026
pulisher
Mar 25, 2026

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Mar 25, 2026
pulisher
Mar 25, 2026

ASBP Soars: Biotech Turbulence Fuels an Unexpected 17% Jump - Bitget

Mar 25, 2026
pulisher
Mar 20, 2026

Aspire Biopharma's Subsidiary Announces Agreement with TruLife Distribution to Drive National Retail Expansion - Black Hills Pioneer

Mar 20, 2026
pulisher
Mar 20, 2026

ASBP Technical Analysis | Trend, Signals & Chart Patterns | ASPIRE BIOPHARMA HOLDINGS IN (NASDAQ:ASBP) - ChartMill

Mar 20, 2026
pulisher
Mar 19, 2026

This caffeine powder skips the drink and is heading to stores nationwide - Stock Titan

Mar 19, 2026
pulisher
Mar 18, 2026

Aspire Biopharma Plunges 19.5% on Intraday Freefall: What’s Fueling the Sharp Drop? - Bitget

Mar 18, 2026
pulisher
Mar 18, 2026

Aspire subsidiary names John Choe as western sales director By Investing.com - Investing.com South Africa

Mar 18, 2026
pulisher
Mar 17, 2026

Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, Partners with Blue Shark Beverages to Expand Southern California Distribution - Record Searchlight

Mar 17, 2026
pulisher
Mar 17, 2026

Aspire subsidiary names John Choe as western sales director - Investing.com

Mar 17, 2026
pulisher
Mar 17, 2026

Aspire Biopharma's Subsidiary, Buzz Bomb Caffeine Company, Appoints John Choe as Western Sales Director - ACCESS Newswire

Mar 17, 2026
pulisher
Mar 17, 2026

He drove 70% sales growth at Yerbaé — now Buzz Bomb hires him - Stock Titan

Mar 17, 2026
pulisher
Mar 17, 2026

Aspire Biopharma Engages with Global Pharmaceutical Leaders at CPHI Frankfurt to Advance Partnership Discussions for its Sublingual High-Dose Aspirin - The Gardner News

Mar 17, 2026
pulisher
Mar 16, 2026

Aspire Biopharma Scales Consumer Division with Delivery of Two Million BUZZ BOMB(TM) Units Featuring Modernized Brand Identity - Erie Times-News

Mar 16, 2026
pulisher
Mar 16, 2026

Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, to Showcase BUZZ BOMB(TM) Caffeine and its Innovative Sublingual Delivery Technology at The Sports & Active Nutrition Summit - The Hutchinson News

Mar 16, 2026
pulisher
Mar 13, 2026

Aspire Biopharma's Subsidiary to Feature BUZZ BOMB(TM) at The Health & Fitness Show 2026 - Black Hills Pioneer

Mar 13, 2026
pulisher
Mar 10, 2026

Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with N - GuruFocus

Mar 10, 2026
$27.36
price up icon 1.82%
$47.03
price up icon 3.20%
$53.54
price up icon 4.29%
$88.77
price up icon 2.26%
ONC ONC
$283.45
price up icon 2.81%
$148.31
price up icon 6.59%
Capitalizzazione:     |  Volume (24 ore):